gip and glp 1 GLP‐1, the two incretin hormones: Similarities and differences Indications for GLP-1/GIP RA Summary

Clinical trial status Eli Lilly is running seven Phase 3 clinical trials evaluating retatrutide for obesity, type 2 diabetes, and related metabolic conditions

Jitters, anxiety, and irritation usually either decrease in the severity or go away completely at some point during the treatment.[3] More serious adverse effects can be life-threatening, and symptoms should not be ignored

what matters is consistent, gradual progress over time

doi: 10.1001/jama.2017.14752

Also, the risk/benefit analysis for a give patient can be very different for achieving desired glycemic management vs attempted body size manipulation

Future research should identify strategies to mitigate pregnancy-related weight gain in people who stop GLP-1s for pregnancy, Maya said